Pilot Study of Laser Interstitial Thermal Therapy Followed By Hypofractionated Radiation Therapy for Treatment of Recurrent Gliomas. (GCCC 19140)

  • days left to enroll
  • participants needed
  • sponsor
    University of Maryland, Baltimore
Updated on 28 October 2022
karnofsky performance status
treatment regimen
brain mri
recurrent tumor


The purpose of this study is to evaluate the treatment regimen of using Laser Interstitial Thermal Therapy (LITT) and Hypo-fractionated Radiation Therapy to treat patients with recurrent gliomas.


Radiation therapy is preferably used as an adjunct to surgery for patients with a newly diagnosed or recurrent glioblastoma. LITT offers an alternative to surgical resection, and due to its minimally invasive nature, does not delay initiating radiation therapy. Another advantage of LITT prior to radiation therapy is the ability to obtain a tissue diagnosis of recurrent tumor prior to initiating radiation therapy.

Condition Glioblastoma, Brain Tumor, Glioma, Neoplasms
Treatment Procedure: LITT, Hypo-Fractionated Radiation Therapy
Clinical Study IdentifierNCT04181684
SponsorUniversity of Maryland, Baltimore
Last Modified on28 October 2022


Yes No Not Sure

Inclusion Criteria

Patients with history of a WHO Grade II-IV glioma with radiographic evidence of recurrent or progressive tumor
Patient must have received prior radiation therapy for initial treatment of glioma
Patients with any number of recurrences are allowed as long as the patient has not undergone re-irradiation
Brain MRI with contrast demonstrates an enhancing tumor ≤ 6 cm in largest diameter
History and physical including neurological exam within 30 days prior to registration
within 60 days prior to registration
Karnofsky performance status ≥ 60% within 30 days prior to registration
Age ≥ 22 years old
Minimum interval since completion of prior radiation treatment is 8 weeks
Patients will only receive re-irradiation if pathology from LITT is consistent with recurrent tumor
Patients must have signed an approved informed consent
Patients with the potential for pregnancy or impregnating their partner must agree to practice effective contraceptive methods to avoid conception while on study and for 6 months after study completion
Female patients of child-bearing potential must have a negative pregnancy test within 28 days prior to study registration

Exclusion Criteria

Patients that are not surgical candidates for stereotactic biopsy or laser ablation
Patients with impaired cardiac function or clinically significant cardiac diseases, including any of the following
History or presence of serious uncontrolled ventricular or significant arrhythmias
Any of the following within 6 months prior to registration: myocardial infarction, severe/unstable angina, coronary artery bypass graft, congestive heart failure, cerebrovascular accident, transient ischemic attack , pulmonary embolism
Infratentorial tumor or evidence of leptomeningeal spread
Inability to undergo a MRI
Pregnant or breast-feeding women
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note